Bovine herpesvirus 4-associated postpartum metritis in a Spanish dairy herd

In more than 10 Spanish dairy cows, a bovine herpesvirus 4 (BHV4) associated postpartum metritis was confirmed by virus isolation, BHV4-glycoprotein B (gB) PCR and/or serology. In this study, 12 cows with, and, at the time of sampling, 3 cows without clinical signs of acute postpartum metritis from one large dairy herd in Spain were examined for bacterial and viral infections. Blood, placenta/caruncles and uterine contents were collected between day 1 and day 20 post-calving, and examined for the presence of bacteria and for viruses by virus isolation, BHV4 DNA by BHV4-gB PCR and/or BHV4 antibody titres. Bovine herpesvirus 4 was detected in 83% of the cases with clinical signs of acute postpartum metritis by virus isolation and/or BHV4-gB PCR. An increase of BHV4 antibodies was detected in all examined postpartum metritis cows and in the 3 cows without clinical metritis. Two of these 3 cows developed severe metritis a few dayss after collecting the first blood sample. A concurrent infections of BHV4 and bacteria, mainly Arcanobacterium pyogenes and Streptococcus sp., were detected in 73% of the examined uterine contents collected from postpartum metritis affected cows. This case-report study showed a clear association between BHV4 infections and acute postpartum metritis in dairy cows. In addition, the BHV4-associated postpartum metritis appeared to be an emerging syndrome in this Spanish herd.     

应用兔肾原代细胞培养 兔粘液瘤病毒的研究

试用兔肾原代细胞传代；增殖兔粘液瘤病毒，呈现典型ＣＰＥ。粘液瘤病毒ＳＧ３３株在兔肾细胞上连续传３代之后，就不产生ＣＰＥ，在鸡胚上传３代再回归兔肾原代细胞，又呈现ＣＰＥ。ＳＧ＿（３３）在鸡胚上不能产生明显痘斑。维持液ｐＨ值影响ＳＧ＿（３３）在兔肾原代细胞上形成ＣＰＥ。     

产蛋下降综合征（EDS－76）病毒DNA探针的制备及应用研究

用纯化的产蛋下降综合征（ＥＤＳ－７６）病毒（Ｈ９１毒株）悬液提取的核酸，经琼脂糖凝胶电泳只出现１条分子量较大、背景清晰的核酸带。用ＢａｍＨＩ酶消化产生４个片段，大小分别为１７ｋｂ、１０ｋｂ、４．０ｋｂ和２．０ｋｂ。将其中的２．０ｋｂ片段克隆进ｐＵＣ１８ＤＮＡ载体中，重组质粒ＤＮＡ用ｄｉｇｏｘｉｇｅｎｉｎ标记作为ＤＮＡ探针，在ｄｏｔｂｌｏｔ中该探针不与鹅胚尿囊液核酸抽提物、马立克氏病病毒（ＭＤＶ）ＤＮＡ、鸡传染性贫血病毒（ＣＡＶ）ＤＮＡ、ＳＰＦ鸡基因组ＤＮＡ等核酸反应，只与３株ＥＤＳ病毒（ＥＤＳ标准毒株ＡＶ－１２７、ＥＤＳＨ９１毒株和从健康鹅体中分离的ＥＤＳＹ８１毒株）ＤＮＡ呈阳性反应。人工感染产蛋母鸡和雏鸡后２４ｈ即可用该探针从泄殖腔棉拭子样品中检测出ＥＤＳ病毒ＤＮＡ，在感染后３５ｈ仍能从部分感染鸡样品中检出。对部分探针检测阳性鸡的泄殖腔棉拭子样品用ＳＰＦ鸡胚分离病毒，并用ＨＡ和ＨＩ试验检测分离病毒的特异性；在感染过程中，同时检测了血清中ＨＩ抗体的消长情况。结果表明，人工感染鸡排毒至少可以维持２个月左右，而且血清中ＨＩ抗体即使很高，也不能阻止感染鸡的排毒。     

猪瘟病毒广西流行毒株E0基因的克隆与分析

应用RT-PCR方法对猪瘟病毒E0基因进行扩增、克隆及测序,用DNA Star分析软件对6株毒株与猪瘟兔化弱毒苗(HCLV)、石门(Shimen)株、Paderborn株、GXWZ02株的相应片段进行比较分析,构建了CSFV遗传进化树。序列分析表明,广西流行株与HCLV株、Shimen株、Paderborn株、GXWZ02株之间核苷酸的同源性分别为80.8%~81.5%、82.8%~83.3%、93.1%~94.2%、93.7%~94.2%,推导的氨基酸同源性分别为88.3%~89.7%、89.7%~91.1%、96.2%~97.7%、97.7%~99.1%;6株广西CSFV流行毒株与国内外已发表的14株病毒相应序列进行比较,构建遗传进化树,结果表明所比较的20株毒株分为2个基因群,广西流行毒株均属于基因群Ⅱ。本研究成功地对广西流行猪瘟病毒株的E0基因进行了测序分析,表明近年来广西流行毒株未发生较大的变异,但病毒株有远离疫苗株发展的趋势。     

鞭毛蛋白及鸡GM-CSF重组新城疫病毒对鸡的免疫增强作用

为评价鼠伤寒沙门氏菌鞭毛蛋白(FliC)以及鸡GM-CSF(chGM-CSF)对新城疫病毒(NDV)弱毒疫苗的免疫增强效果,本实验通过PCR扩增fliC,并合成chGM-CSF编码基因,分别构建重组质粒pBrClone30-fliC和pBrClone30-GM-CSF,拯救获得重组病毒rClone30-fliC和rClone30-GM-CSF。RT-PCR和ELISA检测结果表明:fliC和chGM-CSF基因正确插入重组病毒,并获得稳定表达;重组病毒免疫7 d后重组NDV HI抗体效价检测显示,实验组平均HI效价分别达到4.5 log2和4.8 log2,而r Clone30组和空白组HI效价仅为3 log2和1 log2;免疫7 d后攻毒,空白组SPF鸡均死亡,rClone30组有两例发病,实验组SPF鸡全部存活并且无任何临床症状。本研究结果表明,FliC和chGM-CSF作为佐剂能够有效提高弱毒疫苗的免疫效果。     

In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus

In this work the antiviral activity of 20 dehydroepiandrosterone (DHEA) analogs with different substituents at positions C-3, C-15, C-16 and C-17 were evaluated against vesicular stomatitis virus (VSV) in Vero cell cultures. The selectivity indexes (SI) obtained with DHEA and epiandrosterone (EA) were 50 and 72.6, respectively. The work showed that the compounds 21-norpregna-5,17(20)-dien-3β,16α-diyl-diacetate, 17,17-ethylendioxyandrostan-5,15-dien-3β-ol and 3β-hydroxypregn-17(20)-en-16-one had higher SI values than ribavirin, which was used as a reference drug. The antiviral mode of action of DHEA was also investigated against VSV replication in Vero cells, and time of addition experiments showed that DHEA mainly affected a late event in the virus growth cycle. Analysis of RNA and protein synthesis indicated that DHEA adversely affected positive strand RNA synthesis and viral mature particle formation.     

宿主细胞磷酸激酶在新城疫病毒感染中的作用

为探讨磷酸化通路在新城疫病毒（Newcastle disease virus,NDV）感染中的作用,使用多种蛋白磷酸激酶抑制剂和激活剂预处理细胞,比较处理后NDV在细胞上生长状况的差异。结果显示NDV在PKC蛋白激酶抑制剂处理的细胞上的生长受到抑制,这种抑制作用能够被PKC蛋白激酶激活剂中和,而PKA蛋白激酶抑制剂和p38MAPK蛋白激酶抑制剂对其影响不大。通过PKC蛋白激酶抑制剂的细胞毒性试验证实,这种抑制作用不是由于药物对细胞的毒性或者因药物加入而改变培养基pH值而造成的。病毒在staurosporine处理的细胞上的生长曲线试验显示,浓度在20~200 nmol/L能对病毒感染产生抑制作用,并且药物浓度越高,上清中病毒的滴度相对越低。本研究结果表明PKC磷酸化通路在新城疫病毒的感染过程中发挥了重要作用。     

两株A型禽流感病毒NP基因的PCR扩增及序列分析

研究选择 AIV NP基因为目的基因 ,设计了一对特异性引物 ,筛选出最佳的 RT-PCR扩增条件 ,特异性地扩增出了两株 A型禽流感病毒的部分 NP基因片段 ,并对其进行了序列分析 ,结果表明 ,两株来源于不同禽类的 AIV的NP基因同源率高达 92 %。AIV NP基因结构具有高度保守性     

The epidemiology and diagnosis of bluetongue with particular reference to Corsica

Bluetongue (BT) and/or BT viruses (BTV) have been identified in the Mediterranean basin and the Balkans each year from 1998 to 2002 and in particular BTV serotype 2 in the French Island of Corsica (2000 and 2001). In response to these virus incursions, the French Veterinary Authorities carried out epidemiological studies that included virological, serological and entomological analysis, and two vaccination campaigns performed in the winter of 2000/2001 and the winter and spring of 2001 and 2002. Rapid and reliable serotype differentiation is essential at the start of an outbreak to allow an early selection of vaccine to control the spread of the virus. Thus, molecular tools, that complement conventional methods, have been developed for early detection of infection, determination of the serotype, and differentiation between natural infection and vaccination. Serological results showed that the first vaccination campaign during the winter of 2000/2001 did not provide full protection for all sheep and during the summer of 2001, 335 sheep flocks in Corsica were again infected by BTV 2 (7-fold more that in 2000). Entomological studies have demonstrated that the only proven vector of the disease, Culicoides imicola, was present in the island in 2000 and that it has successfully established itself in Corsica. The safety and immunogenicity of the commercial South African vaccine were studied. Fourteen sheep were vaccinated and then observed for clinical signs. Blood, sera, spleen and lymph nodes were collected and analyzed, and the results confirmed the safety and potency of using this vaccine to protect sheep from clinical disease. As a result, an intensive vaccination campaign was performed during winter and spring 2001/2002. No cases of BT had been observed by the end of summer 2002, indicating that the vaccination campaign has been successful in protecting sheep from infection.